Anti-Infective Agents Market Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others) Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
Current and future Market Scenario According to our new market research study on “Anti-Infective Agents Market to 2028 –Global Analysis and Forecast – by Type, Treatment, and End User,” the market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028. Many well-known firms have medicines that include anti-fungal, antibiotics, bacteria, protozoans, and anti-virals that target cytochrome, interleukin, and interferons, and other multi-drug resistant. The primary factor fueling the anti-infective agents market growth is the rising prevalence of several infectious diseases in developed and developing economies, including various strains of influenza, diarrhea, hepatitis, and urinary tract infections, which call for increased attention from the pharmaceutical & biotechnology industries. Anti-Infective Agents Market
Market Segments Anti-Infective Agents Market By Type Anti-bacterial Anti-viral Anti-fungal and others By Range narrow spectrum and broad spectrum
